Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Breast Neoplasms, Male × Gonadotropin-Releasing Hormone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 24 Breast Neoplasms 4 Leiomyoma 3 Neoplasms 2 Sleep Wake Disorders 1 Prostatectomy 1 Polycystic Ovary Syndrome 1 Pelvic Pain 1 Osteoporosis 1 Neoplasm Metastasis 1 Kallmann Syndrome 1 Hypogonadism 1 Hyperprolactinemia 1 Hemorrhage 1 Fatigue 1 Endometriosis 1 Cardiovascular Diseases 1 Breast Neoplasms, Male 1 Advanced Prostate Cancer 1 Adenomyosis 1

Interventions

Trastuzumab 23 Paclitaxel 21 Cyclophosphamide 19 Docetaxel 16 Taxes 13 Lapatinib 13 Doxorubicin 13 Radiotherapy 12 Bevacizumab 10 Tamoxifen 9 Immunohistochemistry 9 Capecitabine 9 Filgrastim 8 sargramostim 7 Granulocyte-Macrophage Colony-Stimulating Factor 7 Carboplatin 7 Chemotherapy, Adjuvant 6 Biopsy 6 Vorinostat 5 Peripheral Blood Stem Cell Transplantation 5 Magnetic Resonance Spectroscopy 5 Everolimus 5 Erlotinib Hydrochloride 5 liposomal doxorubicin 4 ixabepilone 4 Vinorelbine 4 Immunoenzyme Techniques 4 Gene Expression Profiling 4 Flow Cytometry 4 Cisplatin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01638247 2018-09-19

MALE

GBG Forschungs GmbH

Phase 3 Completed

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡